Did you know most people expect healthcare services to be as relevant as:
You go to your local drugstore and walk out with a new blow dryer and your filled prescription for your newly diagnosed condition. Here are the instructions you received:
We all know the huge impact non-adherence has on patient outcomes (see data below). Which approach do you think would drive behavior change? Communications designed based the unique needs of the target and provides the right support at the right time – or the above?
Bottom line…Non-adherence is associated with higher rates of hospital admissions, suboptimal health outcomes, increased morbidity and mortality, and increased health care costs. 6
It’s no surprise patients (and HCPs) are hungry for support materials. According to a PM360 2017 survey, patients find value in the services provided more than 75% of the time.
A recent Phreesia survey reported that though not many patients see value in support programs, they do want support. From financial and disease information to emotional support.
And not everyone may be a joiner and enroll in a program. But everyone has unmet needs and our role is to provide the multiple points of access to information to drive optimal outcomes.
82% of HCPs say they have seen pharma companies change what they communicate about during the COVID-19 pandemic, delivering not just product information, but support that meets their most pressing needs.
According to the government’s 2016 National Center for Biotechnology Information study, patient support programs positively impact:
And their findings suggest that non-HCP entities (meaning pharma companies, PBMs, etc.) may play an increasingly important role in developing and implementing these programs.
Q: So why do we need ongoing support programs?
A: Because patient adherence barriers are variable and change over time. What was an issue today, may not be an issue tomorrow, and visa versa.